BridgeBio Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.About BBIO
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.
CEONeil Kumar
CEONeil Kumar
Employees730
Employees730
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2015
Founded2015
Employees730
Employees730
BBIO Key Statistics
Market cap6.24B
Market cap6.24B
Price-Earnings ratio-9.14
Price-Earnings ratio-9.14
Dividend yield—
Dividend yield—
Average volume2.17M
Average volume2.17M
High today$33.00
High today$33.00
Low today$31.77
Low today$31.77
Open price$32.56
Open price$32.56
Volume217.68K
Volume217.68K
52 Week high$39.54
52 Week high$39.54
52 Week low$21.62
52 Week low$21.62
BBIO News
Simply Wall St 2d
Possible Bearish Signals With BridgeBio Pharma Insiders Disposing StockMany BridgeBio Pharma, Inc. ( ) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider...
Analyst ratings
84%
of 19 ratingsBuy
84.2%
Hold
15.8%
Sell
0%
People also own
Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.